Amid Global Emergency, FDA OKs Another Vaccine for Mpox "All effective tools" are needed to combat mpox threat, expert says Aug 30, 2024
FDA Releases Final Rule on ID Checks for Tobacco Sales Retailers will soon have to check IDs of any tobacco product customers thought to be under 30 Aug 29, 2024
Congresswomen Press FDA on Delayed Proposal to Ban Hair-Straightening Chemicals Agency has delayed the target date twice Aug 29, 2024
FDA Could Soon Limit Use of Only Drug for COVID Prevention Pemivibart may have reduced activity against growing variant KP.3.1.1, agency warns Aug 27, 2024
Ultraprocessed Foods Are Everywhere. How Bad Are They? These foods make up about 60% of Americans' diets Aug 27, 2024
FDA Clears First Automated Insulin-Delivery Tech for Type 2 Diabetes SmartAdjust technology is used in Insulet's Omnipod 5 Automated Insulin Delivery System Aug 27, 2024
FDA OKs Updated COVID Vaccines mRNA vaccines for 2024-2025 season will target the KP.2 subvariant Aug 22, 2024
Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer Lazertinib plus amivantamab improved PFS by about 7 months versus single-agent osimertinib Aug 20, 2024
FDA OKs First Syphilis Screening Test for At-Home Use Amid a surge in cases, FDA hopes at-home tests will help increase syphilis diagnosis, treatment Aug 16, 2024
FDA Expands Durvalumab Label to Operable Lung Cancer PD-L1 checkpoint inhibitor approved for use in NSCLC before and after surgery Aug 16, 2024
FDA to Challenge Food Industry to Take Up New Sodium Targets Agency hopes mean intake will drop to approximately 2,750 mg/day if companies comply Aug 15, 2024
Novel Agent for Chronic GVHD Wins FDA Approval Axatilimab achieved a 75% response rate in patients with previously treated chronic GVHD Aug 14, 2024
FDA OKs New Option for Primary Biliary Cholangitis Seladelpar improved biochemical response, ALP normalization versus placebo in phase III trial Aug 14, 2024
Blood Test for Colon Cancer: Panacea or Hype? This newly approved testing modality brings challenges and opportunities Aug 14, 2024
IL-31 Drug for Itchy Nodular Skin Disease Gets Thumbs Up From FDA Nemolizumab significantly improved itch, nodules, and sleep disturbance at 16 weeks Aug 13, 2024
FDA OKs Once-Daily Injection for Hypoparathyroidism Palopegteriparatide will be the only drug targeting underlying cause of rare endocrine disorder Aug 12, 2024
FDA Rejects MDMA-Assisted Therapy for PTSD Decision largely expected after agency advisors voted against psychedelic's safety and efficacy Aug 09, 2024
FDA Approves First Emergency Allergy Nasal Spray Neffy is a non-needle-based epinephrine treatment for anaphylaxis and other allergic reactions Aug 09, 2024
New Extended-Release Parkinson's Drug Approved Novel levodopa and carbidopa formulation led to more time without troublesome dyskinesia Aug 08, 2024
IL-2 Receptor-Targeted Therapy Approved for Relapsed/Refractory CTCL New iteration of denileukin diftitox led to objective responses in 36% of pretreated patients Aug 08, 2024
FDA OKs Complement Inhibitor for IgA Nephropathy First-in-class iptacopan approved to reduce proteinuria in adults with rare progressive disease Aug 08, 2024
FDA Approves Vorasidenib for IDH-Mutant Gliomas Treatment improved PFS by 16 months compared with placebo in INDIGO trial Aug 06, 2024
Plant-based Food and Drink Labeling Is a Battlefield Public health considerations are missing in action Aug 06, 2024
Prescription-Free Online Semaglutide Is Risky Business Over 40% of pharmacy sites offering GLP-1 drug without a script are known to operate illegally Aug 05, 2024
FDA Advisors Mostly Convinced Arimoclomol Works for Rare Genetic Disorder If approved, this would be the first drug for Niemann-Pick disease type C Aug 03, 2024
FDA Greenlights First Engineered Cell Therapy for a Solid Tumor Afamitresgene autoleucel (Tecelra) approved for metastatic synovial sarcoma Aug 02, 2024
FDA Panel to Consider Arimoclomol for Rare Genetic Disorder This is the second time the drug has been submitted to the FDA for Niemann-Pick disease type C Aug 01, 2024
FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma Indicated for newly diagnosed patients who are eligible for stem cell transplant Jul 31, 2024
Heavy Metal in Chocolate; Trump 'No Doubt' Hit By Bullet; FDA Cinnamon Warning Grows Health news and commentary gathered by ΔΎΉΟΦ±²₯ staff Jul 31, 2024
Alzheimer's Gets New Galantamine Drug Newly approved prodrug has dual mechanism of action to improve tolerability Jul 30, 2024
FDA Warns of Overdoses With Compounded Semaglutide Multi-dose vials pose complications for self-administration Jul 29, 2024
New Monthly Paliperidone Palmitate Injectable OK'd for Schizophrenia Long-acting intramuscular product approved for schizoaffective disorder as well Jul 29, 2024
FDA Approves Blood Test for Colon Cancer Screening Shield becomes the first liquid biopsy for primary CRC screening Jul 29, 2024
Veterans Lobby for Psychedelic Therapy, but Will It Influence MDMA's Approval? Hurdles remain for FDA application Jul 27, 2024
Third JAK Inhibitor for Alopecia Areata Wins FDA Approval Over 30% of patients had at least 80% scalp hair regrowth with deuruxolitinib Jul 26, 2024
FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials Committee unanimously backs mandating trial design to distinguish effects of therapy phases Jul 25, 2024
'Shambolic' Medical Meeting; DaVita Whistleblower Suit; FDA Mum on MDMA This past week in healthcare investigations Jul 24, 2024
FDA OKs First Orally Dissolving Birth Control Pill Opens up options for people who have trouble swallowing Jul 24, 2024
Trump Talks Cancer Cures, 'Right to Try' as He Accepts GOP Presidential Nomination "We're going to get to the bottom of it" Jul 19, 2024
FDA Allows Best-Selling E-Cigarette Vuse Alto, but Only in Tobacco Flavor Agency previously rejected the company's menthol-flavored products Jul 18, 2024